Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

腺苷酸激酶 环化酶 单克隆抗体 肽 化学 垂体腺苷酸环化酶激活肽 抗体 药理学 生物化学 生物 免疫学 神经肽 酶 血管活性肠肽 受体
作者
Cristina Moldovan Loomis,Benjamin Dutzar,Ethan W. Ojala,Lee Hendrix,Charlie Karasek,Michelle L. Scalley-Kim,Jenny Mulligan,Pei Fan,Jens Billgren,Vanessa Rubin,Heidi Boshaw,Gayle Kwon,Sam Marzolf,Erica Stewart,David Jurchen,Susan M. Pederson,Lisa Perrino McCulloch,Brian Baker,Roger K. Cady,John A Latham
出处
期刊:Journal of Pharmacology and Experimental Therapeutics [American Society for Pharmacology and Experimental Therapeutics]
卷期号:369 (1): 26-36 被引量:60
标识
DOI:10.1124/jpet.118.253443
摘要

Migraine is a debilitating disease that affects almost 15% of the population worldwide and is the first cause of disability in people under 50 years of age, yet its etiology and pathophysiology remain incompletely understood. Recently, small molecules and therapeutic antibodies that block the calcitonin gene-related peptide (CGRP) signaling pathway have reduced migraine occurrence and aborted acute attacks of migraine in clinical trials and provided prevention in patients with episodic and chronic migraine. Heterogeneity is present within each diagnosis and patient's response to treatment, suggesting migraine as a final common pathway potentially activated by multiple mechanisms, e.g., not all migraine attacks respond to or are prevented by anti-CGRP pharmacological interventions. Consequently, other unique mechanisms central to migraine pathogenesis may present new targets for drug development. Pituitary adenylate cyclase-activating peptide (PACAP) is an attractive novel target for treatment of migraines. We generated a specific, high-affinity, neutralizing monoclonal antibody (ALD1910) with reactivity to both PACAP38 and PACAP27. In vitro, ALD1910 effectively antagonizes PACAP38 signaling through the pituitary adenylate cyclase-activating peptide type I receptor, vasoactive intestinal peptide receptor 1, and vasoactive intestinal peptide receptor 2. ALD1910 recognizes a nonlinear epitope within PACAP and blocks its binding to the cell surface. To test ALD1910 antagonistic properties directed against endogenous PACAP, we developed an umbellulone-induced rat model of neurogenic vasodilation and parasympathetic lacrimation. In vivo, this model demonstrates that the antagonistic activity of ALD1910 is dose-dependent, retaining efficacy at doses as low as 0.3 mg/kg. These results indicate that ALD1910 represents a potential therapeutic antibody to address PACAP-mediated migraine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
健壮的涑发布了新的文献求助10
刚刚
刚刚
等月光落雪地完成签到,获得积分10
1秒前
1秒前
FashionBoy的应助被饺子采纳,获得10
2秒前
Ame发布了新的文献求助10
2秒前
2秒前
何文鑫发布了新的文献求助10
3秒前
潇洒依白完成签到,获得积分10
3秒前
甜甜亦丝发布了新的文献求助10
3秒前
七月完成签到,获得积分10
3秒前
4秒前
小刘的应助被少冰少糖加椰果采纳,获得100
4秒前
4秒前
111完成签到,获得积分20
4秒前
hamster666发布了新的文献求助10
4秒前
SS完成签到,获得积分10
4秒前
5秒前
5秒前
ral完成签到,获得积分10
6秒前
第一作者发布了新的文献求助10
7秒前
科研通AI6.3的应助被朝雾采纳,获得10
7秒前
Mole完成签到,获得积分10
8秒前
香蕉君达完成签到,获得积分10
8秒前
消炎药发布了新的文献求助10
8秒前
Ame完成签到,获得积分10
8秒前
吃火龙果不吐米米完成签到 ,获得积分10
8秒前
9秒前
风大大完成签到,获得积分10
10秒前
10秒前
10秒前
琥珀发布了新的文献求助10
10秒前
10秒前
wanci的应助被科研通管家采纳,获得10
11秒前
科目三的应助被科研通管家采纳,获得10
11秒前
11秒前
SciGPT的应助被科研通管家采纳,获得10
11秒前
嘻嘻哈哈的应助被本色风情采纳,获得10
11秒前
11秒前
上官若男的应助被科研通管家采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187918
求助须知:如何正确求助?哪些是违规求助? 9575850
关于积分的说明 21843829
捐赠科研通 7785760
什么是DOI,文献DOI怎么找? 3435128
关于科研通互助平台的介绍 2559501
邀请新用户注册赠送积分活动 2482027